Home / Inspections / 1016583

FDA Inspection 1016583 — Piedmont Reproductive Endocrinology Group, PA

Piedmont Reproductive Endocrinology Group, PA — FEI 3013611101

The FDA completed an inspection of Piedmont Reproductive Endocrinology Group, PA on June 27, 2017 in West Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 27, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
West Columbia, SC (United States)

Facility

Other inspections at this facility

  • 1187380 (NAI Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1091218 (NAI Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources